Now in this study, we found that cGAMP functions as an allergy-prone adjuvant inducing strong type-2 immune responses to co-inhaled allergen in the airway which was dependent on IL-33 and its receptor ST2, which utilize MyD88-dependent signaling pathway. Here, IL33 is linked to allergic disease.